400 related articles for article (PubMed ID: 28893280)
1. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
Pankrac J; Klein K; Mann JFS
AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
[TBL] [Abstract][Full Text] [Related]
2. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
3. Which therapeutic strategy will achieve a cure for HIV-1?
Cillo AR; Mellors JW
Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
[TBL] [Abstract][Full Text] [Related]
5. Latency reversal plus natural killer cells diminish HIV reservoir in vivo.
Kim JT; Zhang TH; Carmona C; Lee B; Seet CS; Kostelny M; Shah N; Chen H; Farrell K; Soliman MSA; Dimapasoc M; Sinani M; Blanco KYR; Bojorquez D; Jiang H; Shi Y; Du Y; Komarova NL; Wodarz D; Wender PA; Marsden MD; Sun R; Zack JA
Nat Commun; 2022 Jan; 13(1):121. PubMed ID: 35013215
[TBL] [Abstract][Full Text] [Related]
6. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.
Chun TW; Fauci AS
AIDS; 2012 Jun; 26(10):1261-8. PubMed ID: 22472858
[TBL] [Abstract][Full Text] [Related]
7. RNA flow cytometric FISH for investigations into HIV immunology, vaccination and cure strategies.
Baxter AE; Niessl J; Morou A; Kaufmann DE
AIDS Res Ther; 2017 Sep; 14(1):40. PubMed ID: 28893281
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
Yang H; Wallace Z; Dorrell L
Front Immunol; 2018; 9():2861. PubMed ID: 30564246
[TBL] [Abstract][Full Text] [Related]
9. The challenge of finding a cure for HIV infection.
Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
[TBL] [Abstract][Full Text] [Related]
10. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
Routy JP; Mehraj V; Cao W
Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
[TBL] [Abstract][Full Text] [Related]
11. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
[TBL] [Abstract][Full Text] [Related]
12. A reservoir for HIV in patients on combination antiretroviral therapy.
Siliciano RF
Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
[TBL] [Abstract][Full Text] [Related]
13. Cure of HIV infection: is the long wait over?
Shearer WT
J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
[No Abstract] [Full Text] [Related]
14. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
Trono D; Van Lint C; Rouzioux C; Verdin E; Barré-Sinoussi F; Chun TW; Chomont N
Science; 2010 Jul; 329(5988):174-80. PubMed ID: 20616270
[TBL] [Abstract][Full Text] [Related]
15. Eradicating HIV-1 infection: seeking to clear a persistent pathogen.
Archin NM; Sung JM; Garrido C; Soriano-Sarabia N; Margolis DM
Nat Rev Microbiol; 2014 Nov; 12(11):750-64. PubMed ID: 25402363
[TBL] [Abstract][Full Text] [Related]
16. Targeted Immune Interventions for an HIV-1 Cure.
Perreau M; Banga R; Pantaleo G
Trends Mol Med; 2017 Oct; 23(10):945-961. PubMed ID: 28890135
[TBL] [Abstract][Full Text] [Related]
17. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
18. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
[TBL] [Abstract][Full Text] [Related]
19. Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse.
Choudhary SK; Archin NM; Cheema M; Dahl NP; Garcia JV; Margolis DM
J Virol; 2012 Jan; 86(1):114-20. PubMed ID: 22013038
[TBL] [Abstract][Full Text] [Related]
20. Toward HIV eradication or remission: the tasks ahead.
Ho DD
Science; 1998 Jun; 280(5371):1866-7. PubMed ID: 9669944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
